Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Kidney Disease”

1,074 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,074 results

Large-scale testing (Phase 3)Study completedNCT00309283
What this trial is testing

Somatostatin in Polycystic Kidney: a Long-term Three Year Follow up Study

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Mario Negri Institute for Pharmacological Research 78
Not applicableUnknownNCT02843334
What this trial is testing

Study of the Prevalence of Fabry Disease in French Dialysis Patients

Who this might be right for
Fabry DiseaseEnd Stage Renal DiseaseRenal Dialysis
Hospices Civils de Lyon 6,000
Not applicableWithdrawnNCT01391975
What this trial is testing

Surveillance and Proactive Intervention for Dialysis Access

Who this might be right for
Renal FailureArteriovenous Fistula
University of Hull
Testing effectiveness (Phase 2)UnknownNCT04940572
What this trial is testing

Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome

Who this might be right for
Wolfram Syndrome
Centre d'Etude des Cellules Souches 23
Not applicableWithdrawnNCT07607600
What this trial is testing

Treatment Patterns, Biochemical Profiles and Clinical Outcomes in Adults With X-Linked Hypophosphatemia

Who this might be right for
X-linked Hypophosphatemia (XLH)
Novo Nordisk A/S
Early research (Phase 1)Study completedNCT02712346
What this trial is testing

The Role of Endothelin-1 in Sickle Cell Disease

Who this might be right for
Sickle Cell Anemia
Augusta University 26
Not applicableActive Not RecruitingNCT06747572
What this trial is testing

Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Vertex Pharmaceuticals Incorporated 401
Not applicableStudy completedNCT03596554
What this trial is testing

X-linked Hypophosphatemia and FGF21

Who this might be right for
X-linked Hypophosphatemia
Hospices Civils de Lyon 39
Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Large-scale testing (Phase 3)UnknownNCT02115659
What this trial is testing

Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Who this might be right for
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Shanghai Changzheng Hospital 100
Testing effectiveness (Phase 2)Study completedNCT02038543
What this trial is testing

Hydroxyproline Influence on Oxalate Metabolism

Who this might be right for
Hyperoxaluria
Mayo Clinic 22
Testing effectiveness (Phase 2)Study completedNCT03526250
What this trial is testing

Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Study completedNCT01732718
What this trial is testing

Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseSickle Cell Nephropathy
University of North Carolina, Chapel Hill 13
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Not applicableLooking for participantsNCT04106479
What this trial is testing

NIRS in Congenital Heart Defects - Correlation With Echocardiography

Who this might be right for
Congenital Heart DefectSingle-ventricleCoarctation of Aorta+8 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 100
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Large-scale testing (Phase 3)Study completedNCT00565097
What this trial is testing

Lanreotide as Treatment of Polycystic Livers

Who this might be right for
Polycystic Liver DiseaseHepatomegalyLiver Diseases+1 more
Radboud University Medical Center 38
Post-approval studies (Phase 4)Study completedNCT02477488
What this trial is testing

Optimal Administration of Allopurinol in Dialysis Patients

Who this might be right for
GoutRenal Insufficiency
Maisonneuve-Rosemont Hospital 50
Testing effectiveness (Phase 2)Study completedNCT01281878
What this trial is testing

Trial on Treatment of Patients With Primary Hyperoxaluria Type I With Pyridoxal-phosphate

Who this might be right for
Primary Hyperoxaluria Type I
University of Cologne 12
Testing effectiveness (Phase 2)Study completedNCT06274489
What this trial is testing

Evaluate Setanaxib in Patients With Alport Syndrome

Who this might be right for
Alport Syndrome
Calliditas Therapeutics AB 20
Next Page